10% discount using “MY10” code for order above $499 + Free Shipping
Price range: $35.00 through $190.00
Brand name – Vilitra 10mg
Generic name – Verdenafil 10mg
Manufacturer – Centurian Laboratories
Packaging – 10 tablets in 1 strip
Vilitra 10mg is a prescription oral tablet containing Vardenafil as its active ingredient. Centurion Laboratories Pvt. Ltd., an established and widely recognized Indian pharmaceutical company, manufactures this medicine. Vardenafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors, commonly known as PDE5 inhibitors. These drugs increase blood flow to the penis during sexual stimulation. As a result, they help men achieve and maintain a firm erection sufficient for satisfying sexual activity.
Vilitra 10mg is the standard starting dose of Vardenafil for erectile dysfunction treatment. It sits below the maximum approved 20mg dose and above any lower trial strength. Doctors prescribe the 10mg dose to most men beginning Vardenafil therapy for the first time. This starting approach allows the doctor to assess the patient’s clinical response and tolerability before deciding whether a dose adjustment is necessary. Additionally, Vardenafil carries a higher binding affinity for the PDE5 enzyme than Sildenafil, the most widely prescribed PDE5 inhibitor. This stronger molecular affinity means Vardenafil can achieve clinically meaningful PDE5 inhibition at lower blood concentrations. As a result, the 10mg dose delivers highly effective erectile support for most men while maintaining a well-tolerated side effect profile.
Doctors prescribe Vilitra 10mg specifically for erectile dysfunction in adult men. Erectile dysfunction is the consistent inability to achieve or maintain a firm erection sufficient for satisfactory sexual intercourse. This condition affects millions of men globally across all age groups and backgrounds. Physical causes include diabetes, cardiovascular disease, high blood pressure, hormonal imbalances, and neurological conditions. Psychological contributors such as performance anxiety, depression, and relationship stress also play a significant role in many cases. Unlike Tadalafil, Vardenafil does not carry a formal approved indication for benign prostatic hyperplasia. Vilitra 10mg is therefore specifically indicated for erectile dysfunction treatment rather than urological symptom management.
Vilitra 10mg suits several patient groups particularly well. First, it is the ideal starting point for most men beginning Vardenafil therapy for the first time. Starting at this dose allows assessment of individual response and tolerability before any escalation to the 20mg maximum. Second, it suits men who respond well to the 10mg dose and do not require the stronger inhibition that 20mg provides. Third, older men and those with mild to moderate health conditions often find the 10mg dose delivers reliable and well-tolerated results without the greater cardiovascular demands of higher doses. Fourth, men with mild to moderate erectile dysfunction who want effective treatment with a lower risk of side effects benefit most from this standard starting strength.
Vardenafil occupies a distinctive clinical position among all approved PDE5 inhibitors. Its binding affinity for the PDE5 enzyme surpasses that of Sildenafil at the molecular level. This greater selectivity for PDE5 means Vardenafil achieves strong erectile enhancement with less off-target enzyme inhibition than Sildenafil at comparable doses. Importantly, Vardenafil also has substantially lower affinity for the PDE6 enzyme in the retina than Sildenafil. The PDE6 enzyme governs color processing in the eye. Lower PDE6 inhibition therefore means significantly fewer color vision disturbances during treatment, which is a notable advantage over Sildenafil for many patients. Furthermore, Vardenafil has a faster onset than Tadalafil in many men. This combination of high PDE5 selectivity, low visual side effects, and fast onset makes Vilitra 10mg a clinically well-differentiated choice.
Centurion Laboratories produces Vilitra 10mg following established pharmaceutical manufacturing protocols that ensure consistent dose delivery and product stability in every tablet. Centurion Laboratories has built a strong and recognized reputation in men’s sexual health medicine across international pharmaceutical markets. Because Vardenafil is one of the most thoroughly studied PDE5 inhibitors in clinical medicine, doctors prescribe Vilitra 10mg with complete confidence in its mechanism, safety profile, and clinical effectiveness. Both patients and healthcare professionals rely on this brand for dependable and consistent therapeutic results.
To understand how Vilitra 10mg works, it helps to first understand the normal physiology of erection and why it fails in men with erectile dysfunction. During sexual stimulation, the nervous system releases nitric oxide into the smooth muscle tissue of the penis. Nitric oxide then activates an enzyme called guanylate cyclase. This enzyme increases levels of a chemical messenger called cyclic guanosine monophosphate, abbreviated as cGMP. The cGMP relaxes smooth muscle cells in the corpus cavernosum, which is the spongy erectile tissue inside the penis. Blood vessels in the penile tissue widen as a result. Blood flows freely into the corpus cavernosum and produces a firm erection sufficient for sexual activity.
In men with erectile dysfunction, an enzyme called PDE5 breaks down cGMP prematurely. This rapid breakdown reduces smooth muscle relaxation, restricts blood vessel dilation, and limits blood flow to the penile tissue. Consequently, the man struggles to achieve or sustain a satisfactory erection even when adequate sexual stimulation is present.
Vardenafil, the active ingredient in Vilitra 10mg, directly blocks the PDE5 enzyme. By doing so, it prevents the premature breakdown of cGMP. Blood vessels in the penile tissue remain relaxed and open as a result. Blood flows freely into the corpus cavernosum, supporting a firm and sustained erection during sexual activity. At the 10mg starting dose, this inhibitory effect on PDE5 produces clinically meaningful erectile enhancement in the majority of men. For most patients, this dose achieves satisfactory results without requiring escalation to the maximum 20mg strength.
The reason Vardenafil achieves strong clinical results at moderate doses is its exceptionally high binding affinity for the PDE5 enzyme. Binding affinity describes how strongly and specifically a drug molecule attaches to its target enzyme. A higher binding affinity means the drug locks onto PDE5 more precisely and with greater molecular strength than competing molecules. Because Vardenafil binds to PDE5 more powerfully than Sildenafil at the molecular level, it can inhibit cGMP breakdown more efficiently at comparable blood concentrations. This pharmacological efficiency is why the 10mg Vardenafil dose produces strong and reliable erectile results in most men beginning treatment.
One of the most important clinical differentiators of Vardenafil is its substantially lower affinity for the PDE6 enzyme compared to Sildenafil. The PDE6 enzyme plays a critical role in the visual signal processing pathway within the retinal photoreceptor cells. Sildenafil inhibits PDE6 to a meaningfully greater degree than Vardenafil at clinically used doses. This PDE6 inhibition by Sildenafil is the reason why some men taking Sildenafil experience temporary blue-tinted vision, increased light sensitivity, or other mild visual disturbances. Because Vardenafil has far less affinity for PDE6, it causes significantly fewer and less pronounced vision-related side effects. This makes Vilitra 10mg a particularly appropriate choice for men who have previously experienced visual side effects on Sildenafil.
Both Vardenafil and Tadalafil are PDE5 inhibitors that effectively treat erectile dysfunction. However, they differ in two important practical ways. First, onset of action differs significantly. Vardenafil typically begins working within 25 to 60 minutes, with some men experiencing effects as early as 15 to 25 minutes on an empty stomach. Tadalafil typically takes 30 to 60 minutes but in some men takes longer. Second, duration differs substantially. Vardenafil lasts four to five hours, while Tadalafil lasts up to 36 hours. Vardenafil therefore suits men who prefer a defined and relatively shorter window of action rather than the extended 36-hour coverage that Tadalafil provides. Men who take other medicines regularly or who prefer more predictable pharmacokinetic timing often favor Vardenafil specifically for this reason.
Vilitra 10mg does not produce automatic erections during ordinary daily activities. Sexual stimulation must always occur first for the medicine to enhance erectile function. The tablet removes the biochemical barrier of premature cGMP breakdown. Without natural sexual arousal, the erection pathway does not activate independently. Men therefore do not experience unwanted or spontaneous erections at any point during daily routines while taking this medicine.
The standard recommended starting dose of Vilitra is one 10mg tablet taken orally approximately 25 to 60 minutes before planned sexual activity. Doctors prescribe this starting dose to assess the patient’s individual response and tolerability before making any escalation decision. If the 10mg dose produces insufficient results after several uses, the doctor may increase the dose to the maximum approved 20mg strength. Conversely, if the 10mg dose produces satisfactory results but with noticeable side effects, the doctor may consider reducing the dose or adjusting timing accordingly.
Swallow the tablet whole with a full glass of water. Do not crush, chew, or split the tablet before swallowing. Unlike Tadalafil, Vardenafil is more sensitive to food interactions. A high-fat meal delays the absorption of Vardenafil and reduces its peak blood concentration, which can slow the onset and weaken the initial effect. For the most reliable and timely onset, men should take Vilitra 10mg on a light meal or an empty stomach whenever possible. Additionally, men must avoid grapefruit and grapefruit juice throughout treatment. Grapefruit inhibits the CYP3A4 liver enzyme responsible for metabolizing Vardenafil. This inhibition causes unpredictable and potentially dangerous increases in Vardenafil blood concentrations.
Because food meaningfully affects Vardenafil absorption, timing the tablet correctly relative to meals is more important with Vilitra than with Tadalafil-based medicines. Taking the tablet on an empty stomach or after a light, low-fat meal produces the fastest and most consistent onset of action. Heavy meals, particularly those high in fat, should be avoided in the two hours before taking the tablet whenever practical. Planning the dosing window with this food consideration in mind helps ensure the most reliable and predictable clinical results from every dose.
Vilitra 10mg is strictly an as-needed medicine. Men should take it only when they plan to engage in sexual activity. Never take more than one tablet within any 24-hour period under any circumstances. Furthermore, never combine Vilitra 10mg with another PDE5 inhibitor such as Sildenafil or Tadalafil within the same dosing window. Combining two PDE5 inhibitors produces additive blood pressure-lowering effects that can become immediately life-threatening.
Elderly men above 65 years of age may require a dose reduction at the starting level. Age-related declines in liver function slow Vardenafil metabolism and increase blood concentrations at any given dose. Doctors often start elderly men at a lower trial dose of 5mg before considering escalation to 10mg. Patients with mild liver impairment generally tolerate Vilitra 10mg. Those with moderate liver impairment may require a dose reduction to 5mg as a starting point. Patients with severe liver impairment must not use Vilitra 10mg at any time. Men with kidney impairment typically do not require dose adjustment at the 10mg level. However, their doctor must individually assess each case before prescribing.
An important clinical consideration specific to Vardenafil is its potential to prolong the QT interval on an electrocardiogram. QT interval prolongation is a change in the electrical activity of the heart that, in certain patients, can increase the risk of an irregular heartbeat called torsades de pointes. Men with a known or suspected prolonged QT interval must not take Vilitra 10mg under any circumstances. Additionally, men taking antiarrhythmic medicines such as quinidine, procainamide, amiodarone, or sotalol must never combine these with Vardenafil. Before prescribing Vilitra 10mg, doctors must review the patient’s cardiac history and current medicine list specifically to identify and exclude this risk.
Always inform the doctor about every medicine currently in use before starting Vilitra 10mg. Particular concern applies to men taking nitrates for chest pain or heart disease, alpha-blockers for blood pressure or prostate management, antifungal medicines, HIV protease inhibitors, CYP3A4-inhibiting antibiotics such as clarithromycin and erythromycin, and antiarrhythmic medicines. These medicines interact with Vardenafil in clinically significant ways and can cause serious cardiovascular complications even at the standard 10mg starting dose. Never self-adjust the dose without direct medical approval from a qualified healthcare professional.
Most men tolerate Vilitra 10mg well when they take it correctly at the prescribed dose. Common side effects include headache, which is the most frequently reported complaint across all PDE5 inhibitors, facial flushing or warmth, nasal congestion or a runny nose, mild indigestion or stomach discomfort, and dizziness. These effects are generally mild to moderate in intensity, self-limiting, and resolve within a few hours without requiring specific treatment. At the 10mg starting dose, side effects tend to occur with lower frequency and lesser intensity than at the maximum 20mg strength.
Back pain and muscle aches occur less consistently with Vardenafil than with Tadalafil. Tadalafil’s inhibition of PDE11 in skeletal muscle tissue is the primary driver of these musculoskeletal effects across PDE5 inhibitors. Vardenafil has lower PDE11 affinity than Tadalafil. Consequently, back pain and muscle aches occur significantly less frequently with Vilitra 10mg than with any Tadalafil-based product. Men who previously experienced troublesome musculoskeletal side effects on Tadalafil often find Vardenafil considerably better tolerated in this regard.
A particularly notable tolerability advantage of Vilitra 10mg is its substantially lower rate of visual side effects compared to Sildenafil. As previously explained, Vardenafil’s much lower PDE6 affinity means it rarely causes the temporary blue-tinted vision or visual brightness disturbances that some men experience on Sildenafil. Men who have previously discontinued Sildenafil due to uncomfortable visual side effects often find Vardenafil produces no such effects at the standard 10mg dose. This improved visual tolerability profile is one of the most clinically meaningful practical advantages Vardenafil holds over Sildenafil in everyday use.
Some men experience mild nausea or temporary mild changes in vision. These effects appear less frequently at the 10mg dose in men with no underlying risk factors. Any persistent or unusual symptom during treatment warrants prompt reporting to the treating doctor for proper clinical assessment. Men must not dismiss or self-manage any side effect that persists beyond a few hours without informing their doctor.
Like all PDE5 inhibitors, Vilitra 10mg lowers blood pressure to a degree. In most healthy men, this blood pressure reduction is modest and clinically well tolerated. However, men with pre-existing low blood pressure, borderline cardiovascular disease, or those taking other blood pressure-lowering medicines require careful clinical assessment before starting Vardenafil therapy. The combination of Vardenafil with alpha-blockers such as doxazosin or tamsulosin also requires careful management. Both medicines lower blood pressure independently. Combining them can produce a sudden and clinically significant drop in blood pressure, particularly when standing up quickly from a seated or lying position.
Although rare, certain serious side effects require urgent medical care. Men must contact a doctor or emergency services immediately if they experience any of the following:
Men taking nitrate medicines such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate for chest pain or heart disease must never take Vilitra 10mg. This combination produces a sudden and severe drop in blood pressure that can become immediately life-threatening. Men taking antiarrhythmic medicines that affect the QT interval must also never combine these with Vilitra 10mg. Men must always inform their doctor and pharmacist about every medicine they currently take, including herbal products and over-the-counter supplements, before starting Vilitra 10mg.
Vilitra 10mg treats erectile dysfunction in adult men by increasing blood flow to the penis during sexual stimulation. It contains Vardenafil, a PDE5 inhibitor with high binding affinity for the PDE5 enzyme and low affinity for the PDE6 retinal enzyme. The 10mg dose is the standard starting strength for most men beginning Vardenafil therapy. It delivers clinically effective erectile support while maintaining a well-tolerated side effect profile appropriate for a first treatment dose.
Both medicines treat erectile dysfunction through PDE5 inhibition. Vardenafil in Vilitra 10mg has a higher molecular binding affinity for PDE5 than Sildenafil. Additionally, Vardenafil has substantially lower affinity for the PDE6 retinal enzyme, meaning it causes fewer color vision disturbances. Both medicines last four to six hours. Some men find Vardenafil acts more quickly or more reliably than Sildenafil due to its stronger PDE5 selectivity. A doctor can help determine which medicine best suits each patient’s individual clinical profile and history.
Vardenafil in Vilitra 10mg acts faster than Tadalafil, with onset in as little as 25 minutes compared to Tadalafil’s typical 30 to 60 minutes. However, Tadalafil lasts up to 36 hours, while Vardenafil lasts four to five hours. Vardenafil causes fewer musculoskeletal side effects than Tadalafil because it has lower PDE11 affinity. Tadalafil also carries an approved indication for BPH, which Vardenafil does not. Men who prefer a shorter, more defined window of action typically favor Vardenafil. Those who prefer prolonged spontaneity typically prefer Tadalafil.
Vilitra 10mg starts working within 25 to 60 minutes of taking the tablet in most men. Some men experience effects as quickly as 15 to 25 minutes on an empty stomach. Because high-fat meals delay Vardenafil absorption, taking the tablet on a light meal or empty stomach produces the fastest and most consistent onset. Men should allow at least 25 minutes after taking the tablet before engaging in sexual activity for the most reliable results.
The effects of Vilitra 10mg last approximately four to five hours after taking the tablet. During this window, men can achieve an erection whenever natural sexual stimulation occurs. The erection develops only in response to stimulation and does not persist constantly throughout the entire window. This four to five hour duration suits men who prefer a clearly defined and relatively short pharmacokinetic window over the extended coverage that Tadalafil provides.
Yes. High-fat meals significantly delay and reduce the peak blood concentration of Vardenafil. This delay slows the onset of action and may weaken the initial erectile response after taking the tablet. For the most reliable and timely effect, men should take Vilitra 10mg on a light meal or an empty stomach. Light meals with low fat content have minimal impact on absorption. Grapefruit and grapefruit juice must be completely avoided at all times during treatment as they inhibit Vardenafil metabolism and cause unpredictable blood concentration increases.
Yes. If Vilitra 10mg produces insufficient erectile improvement after several correctly timed uses, the prescribing doctor may increase the dose to the maximum approved strength of 20mg. This escalation decision belongs entirely to the prescribing physician and must never be self-initiated by the patient. The doctor will assess the patient’s response to the 10mg dose, review tolerability and any side effects experienced, and determine whether escalation to 20mg is clinically appropriate and safe for that individual patient.
Yes, doctors widely prescribe Vardenafil to men with diabetes who experience erectile dysfunction. Diabetes is one of the most prevalent causes of erectile dysfunction because it progressively damages blood vessels and nerves governing erection. Clinical trials consistently confirm that Vardenafil works effectively in diabetic men. However, diabetic men must share their complete medical history and all current medicines with their doctor before starting Vilitra 10mg, particularly given the potential for multiple interacting medicines in this patient group.
Vardenafil has a substantially lower affinity for the PDE6 enzyme in the retina than Sildenafil. The PDE6 enzyme regulates visual signal processing in the eye. Sildenafil inhibits PDE6 to a meaningfully greater degree than Vardenafil at clinically used doses. This difference is why some men on Sildenafil experience temporary blue vision or light sensitivity, while most men on Vardenafil do not. Vilitra 10mg therefore represents a clinically appropriate alternative for men who have previously discontinued Sildenafil due to uncomfortable visual side effects.
Men taking nitrate medicines for heart disease or chest pain must never take Vilitra 10mg. Men with a known or suspected prolonged QT interval, those taking antiarrhythmic medicines affecting the QT interval, men with severe cardiovascular disease, a recent history of heart attack or stroke, very low blood pressure, severe liver disease, or a known allergy to Vardenafil must also not use this medicine. Additionally, Vilitra 10mg is strictly for adult men only. Women, children, and adolescents under 18 years of age must never use it under any circumstances.
Vilitra 10mg represents the most clinically sensible entry point for men beginning Vardenafil therapy for erectile dysfunction. Starting at this dose rather than immediately at the maximum 20mg allows the doctor and patient to establish the minimum effective dose for that individual. This matters for two important reasons. First, using the lowest effective dose minimizes the frequency and intensity of side effects throughout the entire treatment course. Second, it preserves the option to escalate to 20mg if needed, providing a clear and well-defined clinical pathway. For most men, the 10mg dose delivers fully satisfactory results without any need for escalation. This means many patients receive optimal treatment at the gentlest available starting strength.
The most important pharmacological advantage of Vardenafil over Sildenafil is its higher molecular binding affinity for the PDE5 enzyme. This stronger binding means Vardenafil locks onto and inhibits PDE5 more efficiently at comparable blood concentrations than Sildenafil. Because of this, men who have previously found Sildenafil insufficiently effective sometimes experience better results with Vardenafil at an equivalent or even lower dose. For men in whom Sildenafil has produced partial but inconsistent results, switching to Vilitra 10mg under medical guidance often produces a more reliable and satisfying clinical outcome. This pharmacological superiority at the enzyme level is the foundation of Vardenafil’s differentiated clinical effectiveness.
For many men, the deciding factor when choosing between Sildenafil and Vardenafil is the visual side effect profile. Sildenafil’s relatively higher PDE6 affinity means a meaningful proportion of men experience temporary blue-tinted vision, increased brightness sensitivity, or blurred vision after taking it. These visual disturbances are not dangerous. However, they are uncomfortable, disruptive to intimacy, and for some men sufficient to discontinue treatment entirely. Vardenafil’s substantially lower PDE6 affinity virtually eliminates this class of side effects for most men at the standard 10mg dose. Men who previously abandoned Sildenafil due to visual discomfort can therefore return to effective erectile dysfunction treatment through Vilitra 10mg without the side effect that caused them to stop.
Tadalafil’s inhibition of the PDE11 enzyme in skeletal muscle produces back pain and muscle aches in a proportion of men. These effects are among the most consistently distinctive complaints associated specifically with Tadalafil across all its approved dose levels. Vardenafil has lower PDE11 affinity than Tadalafil. This difference results in a significantly lower rate of musculoskeletal side effects with Vilitra 10mg compared to any Tadalafil-based product. Men who have previously discontinued Tadalafil because of persistent or significant back pain or muscle discomfort often find that switching to Vardenafil eliminates these complaints entirely. This tolerability advantage represents a meaningful and genuinely practical clinical benefit for a significant subset of patients.
Vardenafil’s onset of action compares very favorably to both Sildenafil and Tadalafil in terms of speed in many men. At the standard 10mg dose taken on a light meal or empty stomach, some men experience clinical effects within 15 to 25 minutes. This rapid onset reduces the advance planning required between taking the tablet and engaging in sexual activity. While Vardenafil does not match Tadalafil’s extended 36-hour coverage, it offers a meaningful spontaneity advantage over Sildenafil in many individual cases. For men who want a fast-acting medicine that produces results within a clearly defined shorter window, Vilitra 10mg strikes an appealing balance between speed, effectiveness, and predictable duration.
Some men prefer Vardenafil’s four to five hour duration specifically because it is shorter and more predictable than Tadalafil’s 36-hour window. Tadalafil’s prolonged elimination period means the medicine remains active in the body for a day and a half after a single dose. For men who take other medicines regularly, this extended interaction window increases the complexity of managing drug interactions. Vardenafil’s shorter duration means the medicine clears the body within a more predictable and manageable timeframe. This characteristic makes Vilitra 10mg particularly suitable for men with complex medical histories, multiple concurrent prescriptions, or those whose doctors prefer a more controllable pharmacokinetic profile throughout treatment.
The 10mg starting dose of Vilitra is especially appropriate for older men and those with mild to moderate health conditions. Advancing age slows liver metabolism, meaning standard doses of any PDE5 inhibitor produce higher blood concentrations in older men than in younger, healthier patients. Starting at 10mg provides meaningful clinical effectiveness while keeping blood concentrations at a level that most elderly men tolerate well. Similarly, men with mild cardiovascular conditions, mild hypertension under treatment, or mild metabolic disorders benefit from beginning at the more conservative 10mg dose rather than starting directly at the 20mg maximum. This cautious, individualized approach to dosing is precisely what responsible erectile dysfunction medicine should reflect.
Vilitra 10mg works effectively across the full range of physical and psychological causes of erectile dysfunction. Diabetes-related vascular damage, hypertension, atherosclerosis, hormonal imbalances, neurological conditions, and post-surgical nerve disruption all impair the cGMP-mediated erection pathway at different points. Vardenafil’s strong PDE5 inhibition restores cGMP availability regardless of which upstream factor reduced it. Equally, psychologically driven erectile dysfunction, where the primary impairment is excessive performance anxiety rather than structural vascular damage, also responds well to Vardenafil. The medicine creates the physiological conditions for a reliable erection, which progressively reduces performance anxiety over time and allows sexual confidence to rebuild naturally.
Centurion Laboratories produces Vilitra 10mg following established pharmaceutical manufacturing protocols that ensure precise dose delivery and product stability in every tablet. At the 10mg starting dose level, manufacturing accuracy is critical. Men using this dose to establish their individual response to Vardenafil need complete assurance that every tablet they take delivers the same consistent amount of active ingredient. Any variability in dose delivery at the starting phase of therapy could mislead the doctor’s assessment of the patient’s true clinical response. Centurion Laboratories applies rigorous quality control across every stage of production to prevent this variability. Patients and prescribing doctors can therefore rely on every Vilitra 10mg tablet for the precise and consistent dose delivery that clinical assessment at this starting strength demands.
Vardenafil is one of the three original approved PDE5 inhibitors, alongside Sildenafil and Tadalafil, and carries decades of robust clinical trial support. Large-scale randomized controlled trials across diverse patient populations consistently confirm its safety, effectiveness, and tolerability at the 10mg dose. Long-term real-world studies further reinforce the positive safety profile established in controlled trial settings. Men who choose Vilitra 10mg therefore begin their treatment on a foundation of clinical evidence as thorough and comprehensive as any other approved erectile dysfunction medicine. Combined with its distinctive pharmacological advantages over both Sildenafil and Tadalafil in specific patient populations, this strong evidence base makes Vilitra 10mg a clinically compelling and medically well-supported choice for men beginning Vardenafil therapy.
Disclaimer: This content serves informational purposes only and does not replace professional medical advice. Always consult a licensed healthcare professional before starting, stopping, or adjusting any prescribed medication.
Mens Health
Mens Health
Mens Health
Mens HealthExplore Medicines
Select Using Category
